Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing isosorbide mononitrate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Accidental nitrate poisoning |
Causative agent |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Intentional nitrate poisoning |
Causative agent |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
forgiftning med nitrat, uvist med hvilken hensigt |
Causative agent |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
1 |
Nitrate vasodilator adverse reaction |
Causative agent |
True |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
1 |
Isosorbide dinitrate adverse reaction (disorder) |
Causative agent |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Parenteral isosorbide dinitrate adverse reaction |
Causative agent |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Oral isosorbide dinitrate adverse reaction |
Causative agent |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Modified release isosorbide dinitrate adverse reaction |
Causative agent |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Isosorbide mononitrate adverse reaction |
Causative agent |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Modified release isosorbide mononitrate adverse reaction |
Causative agent |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
allergi over for vasodilator indeholdende nitrat |
Causative agent |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
allergi over for isosorbiddinitrat |
Causative agent |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
allergi over for isosorbiddinitrat til parenteral anvendelse |
Causative agent |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
allergi over for isosorbiddinitrat til oral anvendelse |
Causative agent |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
allergi over for isosorbiddinitrat med modificeret udløsning |
Causative agent |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
allergi over for isosorbidmononitrat |
Causative agent |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
allergi over for isosorbidmononitrat med modificeret frigivelse |
Causative agent |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
overdosis af nitrat |
Causative agent |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
1 |
Isosorbide dinitrate overdose |
Causative agent |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Isosorbide mononitrate overdose |
Causative agent |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
isosorbidmononitrat kapsel med modificeret udløsning a 60 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
isosorbidmononitrat kapsel med modificeret udløsning a 40 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
isosorbidmononitrat 25 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
isosorbidmononitrat 50 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
isosorbidmononitrat kapsel med modificeret udløsning a 50 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
isosorbidmononitrat 40 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
isosorbidmononitrat kapsel med modificeret udløsning a 25 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Isosorbide mononitrate 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Isosorbide mononitrate 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Isosorbide mononitrate 40 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
isosorbidmononitrat 60 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Product containing aspirin and isosorbide mononitrate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
isosorbidmononitrat 60 mg + aspirin 150 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
isosorbidmononitrat 60 mg + aspirin 75 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Isosorbide dinitrate [generic additions] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
isosorbiddinitrat 5 mg sublingval resoriblet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Isosorbide dinitrate 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Isosorbide dinitrate 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Isosorbide dinitrate 30 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
isosorbiddinitrat 20 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
isosorbiddinitrat 500 µg/ml injektionsvæske, opløsning, hætteglas a 50 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Isosorbide dinitrate 1.25 mg/actuation sublingual spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
isosorbiddinitrat 30 mg spray til transdermal anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
isosorbiddinitrat 40 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
isosorbiddinitrat 1 mg/ml injektionsvæske, opløsning, ampul a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
isosorbiddinitrat 1 mg/ml injektionsvæske, opløsning, hætteglas a 50 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
nitratbaseret vasodilaterende middel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
isosorbiddinitrat med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
isosorbiddinitrat til parenteral anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
isosorbidmononitrat med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
isosorbiddinitrat til oral anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
isosorbiddinitrat til transdermal anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Isosorbide dinitrate 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Product containing precisely isosorbide dinitrate 2.5 milligram/1 each conventional release sublingual tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Isosorbide dinitrate 40 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
isosorbidmononitrat 300 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
isosorbiddinitrat 40 mg kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Pentaerithrityl tetranitrate |
Is a |
True |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Glyceryl trinitrate |
Is a |
True |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
isosorbidmononitrat 120 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Product containing isosorbide dinitrate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Poisoning by nitrate |
Causative agent |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Inositol hexanitrate |
Is a |
True |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Eritrityl tetranitrate |
Is a |
True |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Amyl nitrite (substance) |
Is a |
True |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Methemoglobinemia due to nitrate poisoning (disorder) |
Causative agent |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
1 |
Amyl nitrate |
Is a |
True |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Isosorbide dinitrate (substance) |
Is a |
True |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Product containing precisely inositol niacinate 500 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Product containing precisely inositol niacinate 750 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Inositol nicotinate 200 mg/mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
inositolnicotinat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Isosorbide mononitrate (substance) |
Is a |
True |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
|
Accidental nitrate poisoning |
Causative agent |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
1 |
Intentional nitrate poisoning |
Causative agent |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
1 |
forgiftning med vasodilatator indeholdende nitrat |
Causative agent |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
1 |
allergi over for vasodilator indeholdende nitrat |
Causative agent |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
1 |
Nitrate vasodilator overdose |
Causative agent |
True |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
1 |
Accidental nitrate vasodilator poisoning |
Causative agent |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
1 |
Intentional nitrate vasodilator poisoning |
Causative agent |
False |
Nitrate-based vasodilating agent (substance) |
Inferred relationship |
Some |
1 |